AzTrials
AzTrials

Alcohol Use DisorderNCT07677449

Preventing Harmful Alcohol Use Among Trauma Patients in Cameroon

A study testing Cameroon-Adapted SBIRT in people with Alcohol Use Disorder and Alcohol-Related Injury, run by University of Buea at 1 site in Cameroon.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record

Search all trials

Trial summary

Brief Summary Alcohol use is a major contributor to injury burden in Cameroon, particularly among trauma patients presenting to emergency departments. Despite the strong association between alcohol use and injury, structured alcohol screening and intervention programs are not routinely integrated into trauma care in… Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
Cameroon-Adapted SBIRT
Could I receive a placebo?
No, everyone receives an active treatment
How many people
690 participants
Where
1 siteCameroon
Study dates
Mar 2027to Aug 2030
Phase
Interventional

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Adult trauma patients aged 18 years and older presenting to the Emergency Department of Limbe Regional Hospital.
  • Positive alcohol screening based on the Single Alcohol Screening Question (SASQ).
  • AUDIT-C score ≥4 for men or ≥3 for women.
  • Able to provide informed consent.
  • Resident within the study catchment area and available for follow-up.
  • Access to a telephone or another reliable means of contact for follow-up assessments.

Who cannot join

  • Severe cognitive impairment preventing participation in study procedures or - provision of informed consent.
  • Severe traumatic brain injury or other medical condition requiring immediate life-saving intervention that precludes participation.
  • Current psychosis or severe psychiatric illness preventing meaningful participation in the intervention.
  • In police custody or other circumstances limiting ability to participate in follow-up.
  • Planned relocation outside the study catchment area during the study follow-up period.
  • Previously enrolled in the study.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Serge Ngekeng, PhD in Public Health contact

+237675652562

sergengekeng@gmail.com

Cameroon1 site
  • Limbe Regional Hospital

    Limbe, South-West Region, 00237

    Serge Ngekeng, PhD in public Health, 675652562, sergengekeng@gmail.com

Other trials in Cameroon

About this study

Official title: Implementation of a Culturally Adapted Alcohol Screening, Brief Intervention and Referral to Treatment (SBIRT) Program in Cameroon

Brief Summary

Alcohol use is a major contributor to injury burden in Cameroon, particularly among trauma patients presenting to emergency departments. Despite the strong association between alcohol use and injury, structured alcohol screening and intervention programs are not routinely integrated into trauma care in Cameroon. This study aims to evaluate a Cameroon-adapted Screening, Brief Intervention, and Referral to Treatment (SBIRT) program for trauma patients at the Limbe Regional Hospital.

Read more

The study will be conducted in three phases: (1) training emergency department healthcare providers on a culturally adapted SBIRT program; (2) evaluating the feasibility, acceptability, and fidelity of SBIRT implementation in routine emergency care; and (3) assessing the effectiveness of SBIRT in reducing harmful alcohol use among trauma patients. Healthcare workers will be trained to deliver SBIRT, and eligible trauma patients screening positive for risky alcohol use will be enrolled in a randomized waitlist-controlled trial. Participants will undergo alcohol screening using validated tools and will be followed for six months. Outcomes will include alcohol use measured by the Alcohol Use Disorders Identification Test (AUDIT), phosphatidylethanol (PEth) biomarker levels, referral uptake, implementation outcomes, and patient well-being measures.

The study is expected to generate evidence on the feasibility and effectiveness of integrating alcohol interventions into trauma care in a low-resource setting and inform future scale-up of SBIRT programs in Cameroon and similar settings.

Read the detailed description

Detailed Description

Alcohol use is a major contributor to the burden of injury in Cameroon and other low- and middle-income countries (LMICs). Studies conducted in Cameroon have demonstrated high levels of alcohol use among road users and trauma patients, with substantial proportions of injured patients reporting recent alcohol consumption or testing positive for alcohol at the time of injury. Harmful alcohol use is associated with increased risk of injury, injury recurrence, disability, and mortality. Despite this burden, systematic alcohol screening and intervention services are not routinely integrated into trauma care in Cameroon.

Screening, Brief Intervention, and Referral to Treatment (SBIRT) is an evidence-based approach designed to identify individuals with risky alcohol use, provide brief counseling to promote behavior change, and facilitate referral to treatment when indicated. SBIRT has been successfully implemented in emergency departments and trauma centers in high-income countries and has demonstrated effectiveness in reducing harmful alcohol use and alcohol-related consequences. However, little is known about the feasibility, acceptability, and effectiveness of SBIRT in resource-constrained emergency care settings in sub-Saharan Africa.

The purpose of this study is to evaluate a Cameroon-adapted SBIRT program implemented within the Emergency Department of the Limbe Regional Hospital. The intervention was developed through a participatory adaptation process involving emergency department clinicians, mental health providers, trauma researchers, implementation scientists, and other stakeholders to ensure cultural appropriateness and operational feasibility within the Cameroonian healthcare context.

The study has three primary objectives: (1) to train emergency department healthcare providers in delivery of a Cameroon-adapted SBIRT program; (2) to evaluate the feasibility, acceptability, adoption, and fidelity of SBIRT implementation in routine emergency care; and (3) to evaluate the effectiveness of SBIRT in reducing harmful alcohol use among trauma patients.

The study will be conducted in phases. During the preparatory phase, stakeholders will be engaged to refine implementation procedures and pretest the training curriculum. Emergency department healthcare workers, including physicians, nurses, and mental health nurses, will then undergo structured training on alcohol screening, motivational interviewing, brief intervention delivery, and referral procedures. Following training, a transition period will be used to integrate SBIRT into routine emergency department operations and optimize implementation workflows before initiation of full study enrollment.

All eligible adult trauma patients presenting to the Emergency Department will be screened for alcohol use using the Single Alcohol Screening Question (SASQ). Patients reporting alcohol use will complete the Alcohol Use Disorders Identification Test-Consumption (AUDIT-C). Men with AUDIT-C scores of 4 or greater and women with AUDIT-C scores of 3 or greater will be considered positive for risky alcohol use and eligible for study enrollment. Participants will subsequently complete the full Alcohol Use Disorders Identification Test (AUDIT) for characterization of alcohol use severity. Individuals with AUDIT scores of 8 or greater will be referred for additional evaluation and treatment according to the study referral protocol.

Eligible participants will be randomized to either an intervention arm or a waitlist-control arm. Participants assigned to the intervention arm will receive the Cameroon-adapted SBIRT program delivered by trained healthcare workers during their emergency department visit. The intervention consists of alcohol risk screening, personalized feedback regarding alcohol use, a brief motivational interviewing-based counseling session, and referral to treatment when indicated. Participants assigned to the waitlist-control arm will receive usual care during the study period and will be offered the intervention following completion of study follow-up.

Participants will be followed for six months following enrollment. Follow-up assessments will occur at one month, three months, and six months after enrollment. Alcohol use outcomes will be assessed using both self-reported and biological measures. Self-reported alcohol use will be measured using the AUDIT instrument. Biological alcohol use will be assessed using phosphatidylethanol (PEth), a validated biomarker of recent alcohol consumption. Additional outcomes will include referral uptake, treatment engagement, depression symptoms measured using the Patient Health Questionnaire-9 (PHQ-9), and injury-related outcomes.

Implementation outcomes will be evaluated using implementation science frameworks including the Consolidated Framework for Implementation Research (CFIR), Proctor's Implementation Outcomes Framework, and the FRAMES model. Feasibility, acceptability, fidelity, adoption, and implementation determinants will be assessed through implementation monitoring, provider surveys, direct observation of intervention delivery, and qualitative interviews with healthcare workers and patients.

The primary hypothesis is that the Cameroon-adapted SBIRT program can be feasibly integrated into routine emergency department care and that participants receiving the intervention will demonstrate greater reductions in harmful alcohol use over six months compared with participants receiving usual care. The study will generate evidence regarding implementation strategies, intervention effectiveness, and scalability of alcohol interventions in trauma care settings within LMICs.

Results from this study are expected to inform future implementation and scale-up of SBIRT programs in Cameroon and other resource-limited settings. The findings may also provide implementation insights relevant to underserved trauma systems and emergency care settings globally where access to behavioral health and substance use services remains limited.

Being tested
Cameroon-Adapted SBIRT, Usual Care
Keywords
Alcohol Use Disorder (AUD), Alcohol Screening, Alcohol-Related Injury, Screening, Brief Intervention, and Referral to Treatment (SBIRT), Brief Intervention, Emergency Department, Trauma Care, AUDIT-C, Referral to Treatment, Substance Use Intervention, Emergency Medicine, Implementation Science, Injury Prevention, Road Traffic Injury, Trauma Patients
Medical subject headings
Alcoholism, Wounds and Injuries, Emergencies

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Cameroon-Adapted SBIRTBehavioural

    A culturally adapted Screening, Brief Intervention, and Referral to Treatment (SBIRT) program delivered by trained emergency department healthcare workers. The intervention includes alcohol risk screening, brief motivational interviewing-based counseling, and referral to treatment when appropriate.

  • Usual CareOther

    Standard emergency department care without structured SBIRT delivery during the study follow-up period. Participants are offered SBIRT after completing six months of follow-up.

Study groups in NCT07677449
Study groupRoleWhat they receive
Immediate SBIRTExperimentalParticipants receive the Cameroon-adapted Screening, Brief Intervention, and Referral to Treatment (SBIRT) program during their emergency department visit. The intervention includes alcohol screening, personalized feedback, a brief motivational interviewing-based counseling session, and referral to treatment when indicated.
Receives: Behavioral: Cameroon-Adapted SBIRT
Waitlist ControlActive comparatorParticipants receive usual care during the follow-up period and are offered the SBIRT intervention after completion of the six-month follow-up assessment.
Receives: Other: Usual Care

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Alcohol Use at 6 Months

    Change in harmful alcohol use from baseline to 6 months following enrollment, measured using the Alcohol Use Disorders Identification Test-Consumption (AUDIT-C).

    Measured: Baseline and 6 months

  2. Change in Phosphatidylethanol (PEth) Levels

    Change in alcohol consumption measured using phosphatidylethanol (PEth), a biomarker of recent alcohol use, from baseline to 6 months.

    Measured: Baseline and 6 months

Secondary outcomes (8)
  1. Alcohol Use at 1 Month

    Change in Alcohol Use Measured by the Alcohol Use Disorders Identification Test-Consumption (AUDIT-C) score at 1 month following enrollment. The total score ranges from 0 to 12, with higher scores indicating greater alcohol consumption and increased risk of hazardous or harmful drinking.

    Measured: 1 month

  2. Alcohol Use at 3 Months

    Change in Alcohol Use Measured by the Alcohol Use Disorders Identification Test-Consumption (AUDIT-C) score at 3 month following enrollment. The total score ranges from 0 to 12, with higher scores indicating greater alcohol consumption and increased risk of hazardous or harmful drinking.

    Measured: 3 Months

  3. PEth Levels at 1 Month

    PEth concentration at 1 month following enrollment.

    Measured: 1 Month

  4. PEth Levels at 3 months

    PEth concentration at 3 month following enrollment.

    Measured: 3 month

  5. Referral Uptake

    Proportion of participants referred for additional alcohol treatment services who attend at least one referral appointment.

    Measured: Within 6 months

  6. Depressive Symptoms

    Depressive symptoms will be assessed using the Patient Health Questionnaire-9 (PHQ-9), a validated nine-item self-report questionnaire that measures the severity of depressive symptoms over the preceding two weeks. The total score ranges from 0 to 27, with higher scores indicating more severe depressive symptoms

    Measured: Baseline, 1 month, 3 months, and 6 months

  7. SBIRT Delivery Rate

    Proportion of eligible participants who receive all components of the SBIRT intervention.

    Measured: Through study completion, an average of 36 months.

  8. Intervention Fidelity

    Adherence of healthcare workers to SBIRT delivery protocols assessed using structured fidelity checklists.

    Measured: Through study completion, an average of 36 months.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 Jun 2026
  2. Study startMar 2027 (estimated)
  3. Primary completionAug 2030 (estimated)
  4. Study completionAug 2030 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Participants who screen positive for risky alcohol use based on AUDIT-C criteria will be randomly assigned in a 1:1 ratio to either an immediate intervention group or a waitlist-control group. Participants in the immediate intervention group will receive the Cameroon-adapted Screening, Brief Intervention, and Referral to Treatment (SBIRT) program during their emergency department visit. Participants in the waitlist-control group will receive usual care during the study follow-up period and will be offered the SBIRT intervention after completion of the six-month follow-up assessment. All participants will undergo baseline assessment and follow-up evaluations at 1, 3, and 6 months. Outcomes will be compared between groups to evaluate the effectiveness of the intervention.
Masking
None (open label)
Enrolment
690 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07677449
Sponsor's protocol ID
SBIRT_UB
Status last verified
Jun 2026
First submitted
19 Jun 2026
Last updated
30 Jun 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Individual participant data (IPD) will not be made publicly available at this time. The study collects sensitive clinical, behavioral, and biomarker data, and participant confidentiality must be protected. Future sharing of de-identified data may be considered upon reasonable request and subject to applicable ethical, institutional, and regulatory approvals.

Publications

  • Ngekeng S, Kibu O, Oke R, Bassah N, Touko DA, Yost MT, Dissak-Delon F, Tendongfor N, Nguefack-Tsague G, Hubbard A, McCoy SI, Christie SA, Chichom-Mefire A, Juillard C. Prehospital factors associated with mortality among road traffic injury patients: analysis of Cameroon trauma registry data. BMC Emerg Med. 2024 Oct 16;24(1):194. doi: 10.1186/s12873-024-01113-8.

    PubMed 39415156
  • Ngekeng S, Oke R, Yost M, Dissak-Delon F, Hubbard A, McCoy SI, Christie A, Shoptaw S, Chichom-Mefire A, Juillard C. Prevalence and Factors Associated With Alcohol-Related Road Traffic Injuries in Cameroon. J Surg Res. 2024 Oct;302:116-124. doi: 10.1016/j.jss.2024.07.050. Epub 2024 Aug 2.

    PubMed 39096740
  • Babor TF, Del Boca F, Bray JW. Screening, Brief Intervention and Referral to Treatment: implications of SAMHSA's SBIRT initiative for substance abuse policy and practice. Addiction. 2017 Feb;112 Suppl 2:110-117. doi: 10.1111/add.13675.

    PubMed 28074569
  • Babor TF, McRee BG, Kassebaum PA, Grimaldi PL, Ahmed K, Bray J. Screening, Brief Intervention, and Referral to Treatment (SBIRT): toward a public health approach to the management of substance abuse. Subst Abus. 2007;28(3):7-30. doi: 10.1300/J465v28n03_03.

    PubMed 18077300

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in